Polycystic Ovary Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients Diagnosed with Kidney Deficiency and Phlegm-Dampness Type PCOS and Insulin Resistance 2.Women of Reproductive Age Aged 18-40 3.No use of any medications affecting menstruation (e.g. contraceptives hormones or other drugs affecting insulin blood sugar sex hormones and lipid metabolism) or related treatment methods within the past 3 months and no history of abortion 4.Gynecological examination and auxiliary examinations: No organic lesions in internal and external reproductive organs and no other primary diseases 5.Patients who have signed the informed consent form and are willing to bear any potential consequences and risks
Exclusion criteria
Exclusion criteria: 1.Exclusion of patients aged 40 2.Patients with congenital insufficiency in their reproductive system that does not meet the requirements of this study 3.Exclusion of patients with genetically inherited mental disorders 4.Exclusion of patients with organ failure in the liver heart kidneys hematopoietic system etc. 5.Exclusion of patients with special constitutions and a history of severe drug allergies 6.Exclusion of patients who cannot comply with the study protocol 7.Exclusion of patients requiring treatment for other conditions that could affect the study results
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comprehensive efficacy evaluation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Basic body temperature;Syndrome Score;Blood insulin level, blood glucose level and HOMA-IR.;Sex hormone level;Serum inflammatory factors;Gene sequencing.;Metabolomics; | — |
Countries
Chian
Contacts
The Affiliated Hangzhou Traditional Chinese Medicine Hospital of Zhejiang Chinese Medical University